to avoid the use of serum with the risk of falsely positive and negative results , and to quantitatively measure routinely low levels of fdp in plasma , we developed a solid-phase enzyme immunoassay ( eia ) , using a monoclonal antibody ( no . fdp-14 ) .
C0229671
serum
C0032105
plasma